Fullerton CA 乳腺癌临床试验
9项针对 乳腺癌的研究正在 Fullerton及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
招募中3 期
- Providence Medical Foundation, Fullerton
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
招募中3 期
- Providence Medical Foundation-Oncology ( Site 0020), Fullerton
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
招募中3 期
- Providence Medical Foundation ( Site 0080), Fullerton
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
招募中1/2 期
- Providence Medical Foundation, Fullerton
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
招募中3 期
- Providence St. Jude Medical Center - Virginia K. Crosson Cancer Center, Fullerton
E-Mindfulness Approaches for Living After Breast Cancer
招募中3 期
- UCI Health - Yorba Linda, Yorba Linda · 距离 7 英里
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
招募中3 期
- Providence Medical Foundation, Fullerton
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
招募中
- St Jude Heritage Medical Group, Fullerton
Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer
招募中2 期
- St. Joseph Heritage Healthcare, Fullerton
其他城市的 乳腺癌试验
- New York City, NY136 项研究
- Houston, TX126 项研究
- Boston, MA112 项研究
- Nashville, TN81 项研究
- Los Angeles, CA73 项研究
- Edison, NJ68 项研究
- St. Louis, MO64 项研究
- Queens, NY64 项研究
- Durham, NC64 项研究
- Chicago, IL59 项研究
- Philadelphia, PA56 项研究
- Dallas, TX55 项研究
Fullerton的其他研究
- 非小细胞肺癌13 项研究
- 卵巢癌6 项研究
- 狼疮5 项研究
- 癌症（所有类型）5 项研究
- 肺癌4 项研究
- 胰腺癌4 项研究
- 胃癌3 项研究
- 食管癌3 项研究
- 黑色素瘤3 项研究
- 头颈鳞状细胞癌3 项研究
- 精神分裂症3 项研究
- 结直肠癌3 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。